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ABSTRACT
Fear of Pain and Dental Care-Related Fear: Associations with the MC1R Gene
Cameron L. Randall, M.S.
Fear of pain is experienced in acute and chronic pain populations, as well as generally, and
impacts numerous aspects of the pain experience, including pain intensity, pain-related disability,
and pain behavior (e.g., avoidance). A related but separate construct, dental care-related fear,
also is experienced in the general population, and impacts dental treatment-seeking behavior and
oral and systemic health. Very minimal work has addressed the role of genetics in the etiologies
of fear of pain and dental care-related fear. Limited available data suggest that variants of the
melanocortin-1 receptor (MC1R) gene may predict greater levels of dental care-related fear. The
MC1R gene also may be important in the etiology of fear of pain. This study aimed to confirm
that MC1R variant status predicts dental care-related fear and to determine, for the first time,
whether MC1R variant status predicts general fear of pain. Participants were 817 Caucasian
adults (62.5% female, M age = 34.7 years, SD = 8.7) who were part of a larger, cross-sectional
project that sought to identify determinants of oral diseases at the community-, family-, and
individual levels (Center for Oral Health Research in Appalachia, cohort 1; COHRA1).
Participants were genotyped for SNPs on MC1R and completed self-report measures of fear of
pain and dental care-related fear. Variation on MC1R predicted higher levels of dental carerelated fear and fear of pain. Importantly, fear of pain mediated the relation between MC1R
variant status and dental care-related fear, B = 1.60, 95% CI [0.281, 3.056]. MC1R variants may
influence orofacial pain and, in turn, predispose individuals to develop fears about pain. Such
fears influence the pain experience and associated pain behaviors, as well as fears about dental
treatment. This study provides support for small genetic contributions to the
development/maintenance of fear of pain and dental care-related fear. These findings suggest
directions for future research to identify potential targets for intervention in the treatment of fear
of pain and dental care-related fear.
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Fear of Pain and Dental Care-Related Fear: Associations with the MC1R Gene
Fear of pain and dental care-related fear1 both are well-studied phenomena, each
ubiquitous and with far-reaching and important effects on health behavior. Fears about pain and
injury are the third most commonly reported of all fears (Oosterink, de Jongh, & Hoogstraten,
2009), and fear of pain is associated with pain-related disability, pain intensity, and pain
behavior, among other aspects of the pain experience, across medical and general populations
(e.g., Buer & Linton, 2002; Crombez, Vlaeyen, Heuts, & Lysens, 1999; McCracken, Gross,
Aikens, & Carnkike, 1996). Fears about dental treatment, related to but distinct from fear of pain,
is similarly prevalent; in the United States of America, close to half of the population reports
experiencing at least moderate levels of dental care-related fear (Dionne, Gordon, McCullagh, &
Phero, 1998), with between 5 and 10 percent of adults reporting avoidance of necessary dental
treatment as a result of this fear (Milgrom, Weinstein, & Heaton, 2009). Avoidance behaviors
associated with both fear of pain and dental care-related fear detrimentally impact physical and
psychological wellbeing (e.g., Crofts-Barnes, Brough, Beddis, & Girdler, 2010; Schuller,
Willumsen, & Holst, 2003; Verbunt, Seelen, & Vlaeyen, 2004). Critical to reducing the burden
of these phenomena is a more complete conceptualization of their etiologies. Minimal extant
literature addresses the role of genetics in the etiology of dental care-related fear and, at this
time, only one known study addresses the influence of genetic factors on the development and
maintenance of general fear of pain. Knowledge in this area has the potential to significantly
impact these public health concerns.
Role of Genetics in Fear of Pain and Dental Care-Related Fear
Biological factors likely play a role in the development and maintenance of fear in some
individuals. Contemporary psychology, including behavioral neuroscience, acknowledges the

2
importance of biological and genetic factors as predisposing individuals to be more or less likely
to develop psychopathology, including problems such as dental care-related fear (McNeil &
Randall, 2014). Genetic differences may influence across several domains (e.g., anxiety
sensitivity, fear conditioning, cognitive vulnerability, pain sensitivity) whether and how an
individual acquires fears about pain and/or dental treatment. To be sure, the role of genetics in
fear and anxiety is becoming better understood, as much research has focused on the topic.
Over the last several decades, genetics has received much attention in the
psychopathology literature (Malouff, Rooke, & Schutte, 2008). Even before then, researchers
aimed to understand how genetic factors affect human behavior, more widely (Malouff et al.,
2008). The earliest work of this type in the area of anxiety involved family studies, which
provided evidence that anxiety disorders specifically, and probably fear and anxiety more
generally, have a high degree of familial aggregation (Smoller, Block, & Young, 2009). Later,
twin studies offered fairly definitive evidence that anxiety disorders are heritable (Hettema,
Neale, & Kendler, 2001; Smoller et al., 2009) and demonstrated that, while important,
environment does not completely account for observed familial aggregation. Across anxiety
disorders, the degree of heritability appears to be relatively high, with estimates ranging from 2051% (e.g., Distel et al., 2008; Maron, Hettema, & Shlik, 2008; Smoller et al., 2009; Timpano,
Hasler, Riccardi, Murphy, & Schmidt, 2009). Work in behavioral genetics (e.g., Farmer, Eley, &
McGuffin, 2005; Jang & Shikishima, 2009) has targeted the genetic underpinnings of anxiety
disorders, as well as gene-environment interactions, and several genes and associated pathways
have been implicated as important in the pathogenesis of disorders related to fear and anxiety
(e.g., Hudson & Pope, 2007; van Eekelen et al., 2011).
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Genetic variation certainly is responsible, in part, for individual differences in
problematic fear and anxiety, generally. Genetic factors can serve as a diathesis for high levels of
fear via several routes (McNeil & Randall, 2014). With regard to fear of pain, the only known
study to address genetic factors suggests that there is a moderate degree of heritability (i.e., 34%
in a family-based cohort study of adolescents and adults; Randall et al., 2016b). A similar degree
of heritability was observed for dental care-related fear in the same sample (30%), and the
genetic correlation between dental care-related fear and fear of pain was substantial (rhoG =
0.67), providing biological evidence that the two are related but distinct constructs (Randall et
al., 2016b). The first known study of the heritability of dental care-related fear utilized twin
study methodology in a sample of adolescents and estimated heritability to be moderately high
for both boys and girls (30-47%; Ray et al., 2010). In another twin study of dental care-related
fear, moderate heritability (41%) also was found in a sample comprised of individuals aged 2335 years (Vassend et al., 2011). In that study, there was a high degree of genetic correlation
between dental care-related fear and the personality trait neuroticism, leading the authors to
suggest that the two phenotypes are distinct but may share similar etiologies. A genetic
predisposition for higher neuroticism may have a cascade effect on dental care-related fear.
Together, these limited data provide evidence that genetic factors may be especially important in
understanding the observed intergenerational transmission of dental care-related fear (e.g., Lara,
Crego, & Romero-Maroto, 2012; McNeil, Randall, Crout, Weyant, Marazita, 2014).
Extending the conclusions drawn by the results of these heritability studies, candidate
gene analysis recently has been applied to research on dental care-related fear. Long has been
clinical lore that patients with red hair are more sensitive to pain, less likely to experience
analgesia following lidocaine injections, and more likely to be fearful or anxious about
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medical/dental treatment than their blonde-, brown-, or black-haired counterparts (e.g., Flaherty,
2010; Thompson, 2011). Such anecdotes seem to interest the general population, as discussion of
the topic has appeared in high-profile lay press publications like National Geographic (Conant,
2014) and TIME (Melnick, 2010), perpetuating the story. Given this lore, and that variants in the
melanocortin-1 receptor (MC1R) gene cause redheadedness, Binkely and colleagues (2009)
studied the role of the MC1R gene in dental care-related fear and fear of dental pain. Working
under the assumption that resistance to local anesthesia may result in more painful dental
experiences, which may condition fears of dental pain and dental treatment, the researchers
tested whether having MC1R gene variants was associated with fear of dental pain, dental carerelated fear, and avoidance of dental care. Results suggested that MC1R gene variant status (i.e.,
having one or more gene variants versus no variants) predicts greater fear of dental pain and
dental care-related fear (R2 = .18), as well as a two-fold increase in the likelihood of avoiding
dental care. This single study suggests that the MC1R gene may be particularly important for
understanding individual differences in dental care-related fear. Given the well-evidenced
relation between dental care-related fear and fear of pain, more generally, results from the
Binkely et al. (2009) study provide reason to study the potential association between the MC1R
gene and general fear of pain and provide a model for completing candidate gene analysis in the
dental care-related fear and fear of pain arenas.
Melanocortin-1 Receptor Gene, Pain, and Anxiety
Melanocortins are hormones derived from the proopiomelanocortin gene, and refer to
adrenocorticotropin (ACTH) and α-, β-, and γ-melanocyte-stimulating hormones (Chaki &
Okuyama, 2005). These hormones have been implicated in various physiological functions, such
as memory and learning (de Wied & Jolles, 1982), analgesia (Vrinten, Adan, Groen, & Gispen,
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2001; Vrinten, Gispen, Groen, & Adan, 2000), stress responses (Adan et al., 1999; von Frijtag,
Croiset, Gispen, Adan, & Wiegant, 1998), and inflammation (Ceriani, Mcalus, Catania, &
Lipton, 1994), among others (see Chaki & Okuyama, 2005). Five receptors are activated by
melanocortins (MC1R-MC5R), each coded for by different genes, and contributing to different
physiological functions (Chaki & Okuyama, 2005). MC1R plays a major role in skin
pigmentation, and so variations in the MC1R gene, which is on chromosome 16, are associated
with skin fairness and red hair color (Raimondi et al., 2008). It has been suggested that the
MC1R gene also plays a role in other phenotypes. For instance, across people of all
pigmentation, the expressed gene has been found in brain tissue of the pathways responsible for
the experience and processing of pain, anxiety, and fear (Chaki & Okuyama, 2005; Xia,
Wikberg, & Chhajlani, 1995), fitting with evidence that suggests that the related MC4R gene and
the melanocortinergic pathway are important in anxiety behavior (Chaki & Okuyama, 2005; Liu
et al., 2007).
Generally speaking, genetic variation seems to account for small to moderate amounts of
variance in pain perception, with various pathways and mechanisms proposed (see Shi, Cleeland,
Klepstad, Miaskowski, & Pedersen, 2010; Vasileiou, Giaginis, Klonaris, & Theocharis, 2009).
Moreover, differences in pain perception across pain types or modalities, within the same
individual, appear to involve a genetic component (Nielsen et al., 2008). For example, in
addition to the MC1R gene (e.g., Mogil et al., 2005), several genes have been identified as
potentially important in the pain experience, such as the SCN9A (e.g., Drenth & Waxman, 2007),
OPRM1 (e.g., Fillingim et al., 2005), and COMT genes (e.g., Diatchenko et al., 2005; Zubieta et
al., 2003). Animal studies provide strong support that the melanocortin system plays a role in
nociception (e.g., Beltramo et al., 2003). Specifically, MC1R, and thus the MC1R gene, appear to
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play a significant role in acute pain perception, a role that may be sex-specific (e.g., female, but
not male, mice lacking MC1R demonstrate increased tolerance to thermal pain; Delaney,
Keighren, Fleetwood-Walker, & Jackson, 2010). Research with humans has yielded similar
results as the translational work with animals; MC1R genotype affects pain sensitivity, including
dental pain sensitivity (Liem, Joiner, Tsueda, & Sessler, 2005; Mogil et al., 2005), with several
single nucleotide polymorphisms (SNPs) identified as particularly important (García-Borrón,
Sánchez-Laorden, & Jiménez-Cervantes, 2005). Related to pain perception, MC1R gene variants
are associated with reduced efficacy of and increased need for general and local (including
dental) anesthesia (e.g., Liem et al., 2004; Liem et al., 2005; Myles, Buchanan, & Bain, 2012).
MC1R expression and presence of MC1R has been identified in periaqueductal gray
matter cells (Xia et al., 1995), the primary control center for descending pain modulation. There
are no known relevant data indicating the mechanism by which MC1R is associated with pain
perception nor the downstream effects of MC1R variation on protein function as related to pain
experience. However, it has been suggested that central MC1R involvement and/or peripheral
dysfunction activates central MC4Rs to impact pain sensitivity (Andresen, Lunden, Drewes, &
Arendt-Nielsen, 2011), which may partly explain why MC1R variation is correlated with
hypersensitivity to pain.
These data lend themselves to the development of two predictions regarding the relation
between MC1R gene variant status and dental care-related fear: (1) MC1R gene variants produce
heightened pain sensitivity, which may result in more readily conditioned fear of pain and dental
care-related fear, and/or (2) reduced anesthesia efficacy associated with MC1R gene variants
results in more painful dental procedures, which may lead to the conditioning of fear of pain and
dental care-related fear (Binkely et al., 2009). While such explanatory mechanisms are likely
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(and testable), it may also be the case that variants in the MC1R gene impact anxiety generally,
including fears and anxieties about pain and dental treatment. The melanocortin pathway (and
notably MC4R) is involved in emotional stress-induced anxiety and activation of the
hypothalamo-pituitary-adrenal axis (Cragnolini, Schiöth, & Scimonelli, 2005; Liu, Garza, Li, &
Lu, 2013), and anxiety and depression more broadly (Chaki & Okuyama, 2005). Thus, the
related MC1R (and the MC1R gene) may be important in understanding anxieties and fears such
as fear of pain and dental care-related fear. Given that the MC1R and MC4R genes are expressed
in similar regions of the brain (Xia et al., 1995), more research on the less-studied MC1R gene is
necessary in order to determine its potential role in both general and specific fears/anxieties.
Understanding Fear of Pain: A Biopsychosocial Perspective
Pain has been described as “an unpleasant sensory and emotional experience associated
with actual or potential tissue damage, or described in terms of such damage” (International
Association for the Study of Pain Task Force on Taxonomy, 1994, p. 211). Indeed, pain is
complex, and biological predisposition and learning history shape idiosyncratic pain experiences
(International Association for the Study of Pain Task Force on Taxonomy, 1994). Under a
multidimensional and biopsychosocial framework, it has been suggested that several factors
influence an individual’s experience of pain. Specifically, Turk and Flor (1999, p. 20) have
asserted that “predispositional factors and current biological factors may initiate, maintain, and
modulate physical perpetuations; predispositional and current psychological factors influence the
appraisal and perception of internal physiological signs; and social factors shape the behavioral
responses of patients to the perceptions of their physical perturbations.”
Given the affective nature of pain, the experience involves a significant psychological
component. A large body of research suggests that emotions, especially fear and anxiety, play an

8
important role in the experience of pain (e.g., Geisser et al., 1994, McCracken, Zayfert, & Gross,
1992). For example, in several contexts, fear is associated with reports of higher levels of
experienced pain (e.g., Fillingim, 2000; Fillingim, Keefe, Light, Booker, & Maixner, 1996;
Fillingim, King, Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009; van Wijk, de Jongh,
Lindeboom, 2010; van Wijk & Hoogstraten, 2009). Similarly, perceived control is predictive of
pain tolerance and threshold and may reduce autonomic arousal in instances of acute pain
stimulation (Feldner & Hekmat, 2001; Geer, Davison, & Gatchel, 1970). Given the clear relation
between fear/anxiety and pain perception, several researchers and theoreticians have suggested
that fear of pain, specifically, may be a particularly important variable in the experience of pain,
and notably in regard to avoidance and other pain behaviors.
Fear of pain involves irrational dread or apprehension about nociception resulting from
any of a variety of sources (e.g., breaking a bone, falling, receiving an injection, chronic
musculoskeletal pain; see Asmundson, Vlayen, & Crombez, 2004). A model put forth by
Asmundson, Norton, and Vlaeyen (2004) proposes that the fear is directed not just at the paininducing stimuli, but also experiences or behaviors that an individual previously has associated
with pain. As with fears, generally, fear of pain presents as responses in three domains –
physiological, behavioral, and cognitive – with idiosyncratic presentation across individuals, and
interaction between the responses (Asmundson et al., 2004; Lang, 1968). In other words, fear of
pain, as manifested across the three response systems, influences and is influenced by the
perception of pain, physiologic reactivity to pain sensations, pain behavior (e.g., avoidance,
reassurance seeking, help seeking), and cognitions about the pain (e.g., catastrophizing,
misappraisals, misattributions). Several models of the pain experience, the pain-avoidance
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relation, and fear of pain outline the connections between these variables (see Asmundson et al.,
2004).
Impact of Fear of Pain
Across clinical and non-clinical populations, and with regard to both chronic and acute
pain, fear of pain can have a profound impact on individual behavior. For example, it has been
suggested that fear of pain operates to maintain chronic pain over time; even after a muscle or
tissue injury has healed, avoidance behavior is perpetuated by fear of pain and results in
deconditioning (e.g., muscle tissue loss, weight gain, decreased strength; Asmundson, Vlaeyen,
& Crombez, 2004). In a pain-avoidance cycle, avoidance behavior is reinforced when this
deconditioning leads to further pain and negative experiences (Asmundson et al., 2004). Thus, a
vicious cycle is set up such that fear of pain perpetuates and is exacerbated by the experience of
chronic pain.
Fear of pain has been well studied in chronic pain populations (e.g., Hursey & Jacks,
1992; Lee, Chiu, & Lam, 2007; Turk, Robinson, & Burwinkel, 2004; Vlaeyen, de Jongh, Geilen,
Heuts, & van Breuklen, 2001). Fear of pain is associated with or predicts several negative
aspects of the chronic pain experience. For example, fear of pain is positively associated with
pain intensity across several chronic pain populations (e.g., low back pain, headache;
Asmundson, Norton, & Veloso, 1999; Vlaeyen et al., 2001). Fears about pain also are highly
associated with reduction in physical activity and normal movement in people suffering from
chronic low back pain (Verbunt, Seelen, & Vlaeyen, 2004). Additionally, fear of pain is the
strongest predictor of disability and poor behavioral performance in individuals experiencing
chronic pain (Crombez et al., 1999). Moreover, specific fears about pain versus more general
fears or anxieties are associated with maladaptive pain behaviors – notably avoidance,
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complaining, and help-seeking – in individuals with chronic pain (McCracken et al., 1996).
Studies assessing cognitive performance and attention bias in chronic pain samples have
suggested that information processing systems may be significantly influenced by fear of pain,
such that hypervigilance to pain-related stimuli is borne out of fear of pain and maintains pain
behaviors, notably avoidance (Asmundson, Kuperos, & Norton, 1997; van Damme, Crombez,
Eccleston, & Roelofs, 2004). In individuals with chronic pain, fear of pain also may be a critical
part of the mechanism responsible for the relation between anxiety sensitivity and the pain
experience (Ocaňez, McHugh, & Otto, 2010; Zvolensky, Goodie, McNeil, Sperry, & Sorrell,
2001).
The role of fear of pain in non-clinical samples and in the experience of acute pain has
been studied less than in chronic pain samples; however, extant data suggest that fear of pain
exists in the general population (Buer & Linton, 2002) and impacts the perception of acute pain
across experimental and naturalistic contexts. For instance, self-reported pain intensity is
positively associated with fear of pain in cases in which nociception is experimentally induced in
healthy participants using ischemic, electrical, or thermal pain tests (George, Dannecker, &
Robinson, 2006; Roelofs, Peters, Deutz, Spijker, Vlaeyen, 2005). Using a cold pressor paradigm
to experimentally induce pain sensations in a non-clinical sample, fear of pain has been found to
predict self-reported pain intensity over and above catastrophizing (Hirsh, George, Binlosky, &
Robinson, 2008). Early work suggests that the ventral lateral frontal region, responsible for
response regulation, and the anterior and posterior cingulate regions, associated with monitoring
and evaluation of affective responses, may be the parts of the brain that are particularly important
in the relation between fear of pain and acute pain perception (Ochsner et al., 2006). Fear of pain
has been found to predict not only self-reported pain intensity, but also degree of disability, using
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an experimental paradigm that involved exercise-induced musculoskeletal injury (Parr et al.,
2012). Likewise, in a sample of individuals experiencing acute low back pain, fear of pain was
negatively associated with change in disability, even after controlling for pain intensity (George,
Fritz, & McNeil, 2006). Together, the evidence from studies utilizing clinical and non-clinical
samples, across acute and chronic pain experience, suggests that fear of pain undoubtedly plays a
critical role in the perception of nociception and in an individual’s behavioral response to pain.
Fear of Pain and its Relation to Dental Pain
Though the literature is limited, experimental evidence suggests that sensitivity to one
type of pain is not necessarily a good indication of sensitivity to other types of pain. For
example, individuals often demonstrate varying degrees of pain tolerance and threshold across
different types of experimentally-induced pain (i.e., thermal versus pressure versus electrical
stimulation; Janal, Glusman, Kuhl, & Clark, 1994). Complicating our understanding of
nociception even further, it is clear that individuals demonstrate varying pain sensitivity across
organ systems and regions of the body, with psychological variables playing a role. Notably,
dental pain sensitivity appears to be related to, but distinct from, pain sensitivity in other parts of
the body. For instance, Kelpac, Dowling, and Hauge (1982) found significant differences in
dental pain tolerance, but not non-dental pain tolerance, between individuals who were and were
not fearful of dental treatment.
Indeed, the experience of oral/dental pain is unique, compared to bodily pain in other
areas, and even is described differently by individuals who are in pain (e.g., Grushka & Sessle,
1984; McNeil, Vargovich, Sorrell, & Vowles, 2014). Several factors may be important for the
difference between dental and other pain, such as the way in which teeth are innervated
compared to innervation of other parts of the body (Fried, Sessle, & Devor, 2001; Hildebrand,
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Fried, Tuisku, & Johansson, 1995; McNeil et al., 2014). Though dental professionals concern
themselves with pain conditions of the hard and soft tissues of the head, face, neck, and intraoral
cavity, collectively understood as orofacial pain (de Leeuw, 2008), dental pain often is
conceptualized by others as toothache, injury to the teeth or jaw, or pain related to dental
procedures (e.g., restoration, extraction, endodontic therapy; McNeil et al., 2014). Dental pain
commonly is experienced, manifests in a variety of ways, and can be influenced by numerous
biological, psychological, social, and environmental factors (McNeil et al., 2014).
Few studies have addressed the relation between fear of pain and perceived orofacial or
dental pain; however, available data suggest that, like other types of pain, fear of pain impacts
the experience of orofacial pain. The earliest work in the area provided evidence that orofacial
pain patients, compared to matched healthy controls, report greater levels of general fear of pain,
especially fear of severe pain (McNeil et al., 2001). Fear of dental pain, specifically, has been
positively associated with experiencing greater duration and intensity of pain resulting from an
intraoral injection (van Wijk & Hoogstraten, 2009). Not surprisingly, individuals who have
experienced dental pain overestimate fear of specific dental pains (van Wijk & Hoogstraten,
2005). Though additional work is necessary to more definitively demonstrate a link between fear
of pain and dental pain specifically, existing literature indicates that fear of dental pain and
experienced orofacial and/or dental pain are related in a bidirectional or cyclical manner.
Fear of Pain is a Critical Component of Dental Care-Related Fear
Given the potential for pain in dental treatment, several researchers have focused
attention on the relations among orofacial pain, fears about pain, and fears about dental
treatment, more generally. To be certain, a relatively large body of evidence provides support for
a strong association between fear of pain and dental care-related fear. McNeil and Berryman
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(1989) published the first known data suggesting that fear of pain is a key component of dental
care-related fear. This finding has been replicated across several clinical and community samples
and across age groups (e.g., McNeil et al., 2001; McNeil et al., 2011; McNeil et al., 2013;
Randall, McNeil, & Stuchell, 2012; Randall, et al., 2016b). Relatedly, fear of dental pain,
specifically, has been associated with dental care-related fear in several studies (e.g., Binkley et
al., 2009; van Wijk & Hoogstraten, 2003). It appears that fearing nociception associated with
dental treatment may predispose or reinforce in patients dental care-related fear (McNeil &
Randall, 2014).
Understanding Dental Care-Related Fear and Anxiety: Conceptual and Etiological Issues
Dental care-related fear and anxiety are distinct but related phenomena, with complex
etiologies, that are ubiquitous and impact health behavior. As a result of their associations with
oral, systemic, and psychological health, and their widespread prevalence, dental care-related
fear and anxiety represent public health concerns that warrant scientific and clinical attention.
Though complete conceptualizations of these phenomena still are being constructed, much
already is understood about the development, maintenance, and implications of them. To begin,
dental care-related fear and anxiety, just as with fears and anxieties related to other stimuli, are
separate phenomena, even if there is significant overlap (McNeil, Vrana, Melamed, Cuthbert, &
Lang, 1992; Poulton, Waldie, Thomson, & Locker, 2001). Typically, dental care-related fear
describes an individual’s physiological, behavioral, and cognitive responses to dental stimuli,
almost always occurring in the immediate presence of those stimuli (Craske, 2003; Lang, 1968).
Specifically, dental care-related fear often is characterized by physiological responsivity,
avoidance behavior, and feelings and verbal report of apprehension or tension, with the
physiological component particularly strong (Craske, 2003; McNeil & Randall, 2014). Dental
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care-related anxiety, on the other hand, describes an emotional response to stimuli related to
dental treatment that often occurs prior to and in anticipation of encountering the stimuli.
Cognitions, namely negative thoughts and worries, are a key feature of anxiety, often playing
much more of a role than in the fear response (Craske, 2003; McNeil & Randall, 2014). Most
“nervous” dental patients experience both dental care-related fear and anxiety. Available
psychometrically sound measures of dental care-related fear and anxiety do not make a
distinction between the two phenomena; therefore, for the purposes of this study, ‘dental carerelated fear’ will refer to what likely is both dental care-related fear and/or anxiety.
Though often incorrectly thought of as binary phenomena (i.e., fearful or non-fearful),
contemporary conceptualizations of dental care-related fear and anxiety consider their experience
as falling somewhere on a continuum (see McNeil & Randall, 2014). That is, dental care-related
fear and anxiety are dimensional, with patients experiencing any of a range of levels of fear or
anxiety, from no fear/anxiety at all to “normal” levels of fear/anxiety to significant or even
phobic levels of fear/anxiety. At very high or phobic levels, dental care-related fear probably best
is conceptualized as Specific Phobia, Situational Type (de Jongh et al., 1998; Leutgeb, Schäfer,
& Schienle, 2011; McNeil & Randall, 2014). The most recent iteration of the Diagnostic and
Statistical Manual for Mental Disorders (5th ed.; DSM-5; American Psychiatric Association,
2013) suggests that all instances of dental phobia should be categorized as Blood-Injury-Illness
(BII) Phobia; however, given what is known about dental phobia, this categorization is not
always appropriate and such a diagnostic strategy therefore may be inaccurate (see McNeil &
Randall, 2014). Of course, in some cases, dental care-related fear can be well understood as a BII
Phobia or as an injection phobia (McNeil & Randall, 2014). Still, it should be reiterated that
patients need not experience phobic levels of dental care-related fear in order for the fear to
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manifest in a noteworthy or impactful manner. Individuals along the continuum of dental carerelated fear have a unique and idiosyncratic experience and presentation of fear, or alternatively,
comfort, related to dental situations.
Several mechanisms describing the developing and maintaining factors of dental carerelated fear have been posited. Thus, a number of etiological factors can explain dental carerelated fear, with current conceptualizations combining many of the models (see McNeil &
Randall, 2014). First, conditioning models suggest that dental care-related fear develops and is
maintained through classical and operant conditioning paradigms. For example, fear of the dental
situation may be the result of, and perpetuated by, associations made between dental stimuli
(e.g., the sound of a drill) and aversive experiences (e.g., pain, lack of control; Davey, 1989;
Kent, 1985). Likewise, dental care-related fear may develop via positive reinforcement when a
child displaying fear behavior encounters special attention from the dental professional or a
parent, or via negative reinforcement, when fear behavior (e.g., squirming, taking frequent
breaks) provides relief from aversive dental stimuli (McNeil & Randall, 2014). Newer
conditioning models have highlighted the role of avoidance in maintaining dental care-related
fear. A vicious cycle of dental care-related fear has been described such that a negative dental
experience leads to dental care-related fear, which leads to avoidance of dental treatment, and
then to dental problems, and thus additional aversive dental experiences, completing the cycle by
perpetuating dental care-related fear (see Armfield, Stewart, & Spencer, 2007).
Second, social learning theory has been applied to dental care-related fear. These
conceptualizations of the etiology of fears about dentistry suggest that, through observational or
vicarious learning mechanisms, dental patients become fearful, even when they never have
experienced painful or negative dental situations, by learning about the (potentially) aversive

16
nature of dental procedures from family, friends, or the media (McNeil, Randall et al., 2014;
Melamed & Williamson, 1991; Milgrom et al., 2009).
Third, cognitive models of the acquisition and maintenance of dental care-related fear
propose that misperceptions, misattributions, cognitive biases, and negative thinking patterns are
critical. Data suggest that misappriasing risk and thinking patterns that involve catastrophizing
are important moderators of dental care-related fear (de Jongh, Muris, ter Horst, van Zuuren, &
de Wit, 1994). A cognitive vulnerability model describes dental care-related fear as being the
result, at least in part, of maladaptive thinking style and misperceptions about controllability,
predictability, dangerousness, and disgustingness (Armfield, 2006; 2010a). Learning history and
genetic predispositions related to anxiety likely are important in this cognitive vulnerability
(McNeil & Randall, 2014).
Fourth, models that include personality traits suggest that the etiology of dental carerelated fear involves stable trait anxiety and/or neuroticism, and some data support such models
(Thomson, Broadbent, Locker, & Poulton, 2009; Vassend, Roysamb, & Nielsen, 2011). Lastly,
pain-related factors may be particularly important in understanding the etiology of dental carerelated fear. For instance, heightened pain sensitivity and low pain tolerance/threshold may
provide a critical vulnerability for dental care-related fear (Bernstein, Kleinknecht, & Alexander,
1979; Wardle, 1982). Several studies highlight the importance of pain perception in the
experience of dental care-related fear (e.g., Sandikop, Agrawal, & Patil, 2011; Tickle, Milsom,
Crawford, & Agrawal, 2012; van Wijk & Makkes, 2008). A comprehensive conceptual model
describing dental care-related fear, and incorporating each of these important etiological factors,
has been proposed by McNeil and Randall (2014; see Appendix A). That model includes
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biological and genetic factors, which also are theoretically important. Given that these factors are
understudied, they are the subject of this project.
Impact of Dental Care-Related Fear
As noted earlier, dental care-related fear is common, with 45 million adults living in the
USA reporting at least moderate levels (Dionne et al., 1998), and similar rates reported in other
parts of the world (e.g., Armfield et al., 2006; Domoto et al., 1988; Klinberg, Berggren, &
Noren, 1994; Moore, Birn, Kirkegaard, Brodsgaard & Scheutz, 1993). The most recent metaanalysis on the topic suggests that between 10 and 20% of American adults report a high degree
of dental care-related fear, a prevalence rate that has remained stable over the last six decades,
even though dental treatment has seen vast improvements in quality and comfort (Smith &
Heaton, 2003). Dental phobia, dental care-related fear at the extreme, is the third most prevalent
phobia (Oosterink et al., 2009). Clearly, dental care-related fear affects a great number of people.
It should be noted, however, that this fear is not distributed evenly across the population.
Consistently published is the finding that more women, compared to men, report higher levels of
dental care-related fear (e.g., Craske, 2003; Doerr Doerr, Lang, Nyquist, & Ronis, 1998; Heft,
Meng, Bradley, & Lang, 2007; Liddell & Locker, 1997); the reasons for this sex difference are
not completely known (McNeil & Randall, 2014). Across ages, there is a bimodal distribution of
dental care-related fear in the population, with young adults and middle-aged adults reporting
higher levels of fear (Oosterink et al., 2009), and older adults reporting lower levels of fear
(Armfield, Spencer, & Stewart, 2006; Locker & Liddel, 1991), relative to other age groups.
Among other demographic variables, lower socioeconomic status appears to be related to greater
levels of dental care-related fear (Armfield et al., 2006; Doerr et al., 1998).

18
A defining manifestation of fear is avoidance behavior, and dental care-related fear, not
surprisingly, leads to (and is exacerbated by) avoidance of both asymptomatic and symptomatic
dental treatment. Specifically, dental care-related fear is negatively associated with frequency of
dental check-ups (Doerr et al., 1998), and positively associated with avoidance of dental
appointment scheduling (Meng, Heft, Bradley, & Lang, 2007) and avoidance of dental treatment
(Armfield et al., 2007). These associations are demonstrated even when controlling for
socioeconomic status and treatment accessibility. Not surprisingly, treatment avoidance is
correlated with poorer oral health (e.g., decayed and missing teeth, fewer functional teeth;
Schuller et al., 2003). Treatment avoidance has been suggested as serving a mediating role in the
predictive positive association between dental care-related fear and number of decayed and
missing teeth, and predictive negative association between fear and number of filled teeth, as
observed in two large-scale, community-based studies (Armfield, Slade, & Spencer, 2009;
Randall, McNeil, Wiener et al., 2013). In addition to treatment avoidance, dental care-related
fear also is negatively associated with oral self-care, such as brushing, flossing, and compliance
with treatment regimens (Ojima et al., 2005; Riley, Gilbert, & Heft, 2006). Taken together,
available data provide substantial support that dental care-related fear greatly impacts dental care
utilization and associated oral health status.
Poorer oral health associated with dental care-related fear has been tied to several
negative psychological outcomes. For example, dental care-related fear and associated oral
health outcomes are positively correlated with dissatisfaction with one’s mouth (Doerr et al.,
1998). Dental care-related fear also is associated with lower quality of life (Crofts-Barnes et al.,
2010) and lower self-esteem and morale (Locker, 2003).
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Similarly, a large body of literature has linked poorer oral health with numerous negative
systemic health outcomes. For instance, untreated dental disease may exacerbate diabetes and
cardiovascular disease (Williams et al., 2008). Epidemiological and laboratory studies suggest
that periodontal infections increase the risk for and worsen atherosclerosis and pulmonary
infections (Scannapieco & Genco, 1999). Likewise, periodontal disease has been linked to
increased risk for coronary heart disease (Morrison, Ellison, & Taylor, 1999) and
cerebrovascular disease (Wu et al., 2000). Several mechanisms have been proposed to explain
the relation between systemic disease and oral infection, such as metastatic spread of infection,
metastatic injury by circulating toxins, and metastatic inflammation caused by that injury (Li,
Kolltveit, Tronstad, & Olsen, 2000), and early evidence suggests that the link between dental and
systemic diseases is causal in nature (Haumschild & Haumschild, 2009; Joshipura, Ritchie,
Douglass, 2000). Relatedly, untreated dental disease also is associated with worse pregnancy
outcomes, possibly the result of infection affecting the unborn fetus (e.g., Gaffield, ColleyGilbert, Malvitz, & Romaguera, 2001; Offenbacher et al., 1996). Given the far-reaching impact
of dental care-related fear, and the high prevalence worldwide, dental care-related fear often is
considered a public health concern (McNeil & Randall, 2014).
Statement of the Problem and Study Aims
Fear of pain and dental care-related fear both are complex phenomena with multifactorial
etiologies across the population (Asmundson et al., 2004; McNeil & Randall, 2014). As outlined
earlier, high levels of general fear of pain are positively associated with pain-related disability,
pain intensity, and chronic pain behavior. Similarly negative states associated with dental carerelated fear include avoidance of dental treatment and poorer oral, systemic, and psychological
health, among others, as discussed above. Fear of pain appears to be a critical component of
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dental care-related fear (e.g., McNeil & Berryman, 1989), though also is important in its own
right (i.e., in understanding the pain experience across numerous populations and pain
conditions). Improving our understanding of fear of pain and fears about dental treatment, both
separately and as related constructs, may inform interventions aimed at reducing the burden of
these phenomena.
Though much is known about the etiology of both general fear of pain and dental carerelated fear, there is a dearth of literature addressing the role of genetics. A single study has
estimated the heritability of fear of pain, with no other known work on the impact of genetic
factors on the development and maintenance of the phenotype. In the dental care-related fear
literature, only four known studies have sought to elucidate the role of genes in predisposing
individuals to clinically significant levels of fear. Nevertheless, biological and genetic variables
likely are etiologically important for both fear of pain and dental care-related fear (McNeil &
Randall, 2014). Studies that assess the role of genetics in these phenomena are necessary in order
for their conceptualizations to be more comprehensive and complete. An understanding of fear of
pain and dental care-related fear that includes genetic variables has the potential to shape
personalized interventions that are most efficacious (i.e., personalized medicine and dentistry).
The central goal of the current study was to expand upon the limited genetic knowledge
related to fear of pain and dental care-related fear. With regard to the comprehensive conceptual
model describing dental care-related fear proposed by McNeil and Randall (2014) and
acknowledged earlier, the current study was designed to provide evidence for associations
between the components of the model highlighted in Figure 1. Given the theoretically important
and previously identified association between dental care-related fear and the MC1R gene, the
first aim of the study was to determine whether MC1R gene variant status predicts dental care-
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related fear, with the expectation of replicating the findings of the Binkely et al. (2009) study.
The second aim of the study was to, for the first time, determine whether MC1R gene variant
status predicts general fear of pain. The third aim of the study was to examine whether fear of
pain mediates the association between MC1R gene variant status and dental care-related fear.
Finally, as a secondary objective, the study explored whether other candidate genes are related to
fear of pain and dental care-related fear. The ultimate goal of this project was to contribute to
two bodies of literature – fear of pain and dental care-related fear – such that conceptualizations
of these public health problems may be refined in ways that can influence the development and
implementation of the treatments that target them.
Hypotheses
First, drawing on previous research (Binkley et al., 2009), it was hypothesized that MC1R
gene variant status would predict level of dental care-related fear in a large Appalachian
community sample of adults (Hypothesis 1). Second, given the relation previously observed
between MC1R gene variant status and fear of dental pain (Binkely et al., 2009), and the wellreplicated finding that dental care-related fear and general fear of pain are associated (e.g.,
McNeil & Berryman, 1989), it was expected that MC1R variant status would predict level of
general fear of pain in the same sample (Hypothesis 2). Third, and conditional on results
supporting Hypotheses 2 and 3, it was anticipated that the relation between MC1R gene variant
status and dental care-related fear would be mediated by fear of pain (Hypothesis 3).
Method
Design
The current investigation utilized existing data from a large, family-based study of the
Center for Oral Health Research in Appalachia, cohort 1 (COHRA1), the same data set from
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which the previously reported heritability estimates for fear of pain and dental care-related fear
were calculated (Randall et al., 2016b). The larger, cross-sectional project was initiated to
identify in an Appalachian sample determinants of oral diseases at the community-, family-, and
individual levels, and data were collected over a seven-year period. A comprehensive protocol
included a large battery of self-report measures related to several aspects of oral health
(including psychosocial ones), standardized interviews, oral health assessment, microbiological
assessment, and DNA collection. The study protocol was developed by a committee with
expertise in genetics, microbiology, epidemiology, biostatistics, behavioral science, community
assessment, rural health, and dentistry (Polk et al., 2008). A complete description of the study
protocol is beyond the scope of this manuscript; it has been described elsewhere (see Marazita et
al., 2005; Polk et al., 2008). Methods of self-report data collection for this study have been
outlined and critiqued (see Randall, McNeil, Crout et al., 2013). Written informed consent was
obtained from adult participants and parents or legal guardians of child participants; verbal
assent was obtained from children who could grant assent. The study design and all materials
were approved by the Institutional Review Boards of West Virginia University and the
University of Pittsburgh.
Participants
Participants were recruited in Webster and Nicholas counties of West Virginia and
Allegheny, Washington, and McKean counties of Pennsylvania. According to the householdbased protocol, eligibility criteria required that households must contain at least one biological
parent-child (i.e., age 1 to 18 years) pair. All members of eligible households who volunteered
were invited to participate, without regard to biological or legal relationships and without regard
to oral health status. Psychosis, neurological impairment, and severe physical or mental disability

23
comprised participant exclusion criteria. Households were excluded if at least one member of the
biological parent-offspring pair exhibited impaired blood clotting or diminished capacity to resist
infection. Given the recruitment strategy, a community-based sample that reflects a range of the
Appalachian population was obtained – a notable range in socioeconomic statuses, cultural
behaviors, attitudes, and access to oral health care was observed (Polk et al., 2008). Additionally,
racial and ethnic composition of this part of the Appalachian region was reflected in the sample
(Polk et al., 2008). On the whole, participants in this sample, as compared to the greater USA
population, were socioeconomically disadvantaged and suffered from poorer oral health across
several indices (e.g., Martin et al., 2008; Shaffer et al., 2012; Wang et al., 2010).
In total, 732 households were enrolled in the COHRA1 study, with 2,663 individuals
participating from 740 biological families. For the proposed project, only genotyped participants
who completed measures of fear of pain and dental care-related fear were included in analyses
(participants age 11 years and older completed such measures). To ensure participant
independence, only those who were not genetically related were included in the sample (e.g.,
included only one member [mother] of a biological mother-child pair); the result was the
inclusion of only adults, as children were enrolled in the COHRA1 study as a function of
relatedness to at least one enrolled parent and, for the current study, parents were selected for
over children in the elimination of genetically related participants. Furthermore, in keeping with
human MC1R studies (e.g., Binkely et al., 2009, Liem et al., 2005), and to allow for
straightforward comparison, only self-reported Caucasian/white participants were included in
final analyses.2 Thus, the current study involved the analysis of data for 817 participants. Figure
2 depicts the selection of these participants from the full COHRA1 sample.
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Self-Report Assessment Instruments
Demographic questionnaire. A questionnaire designed to collect demographic
information was developed specifically for the purposes of the COHRA1 study, and variables
included are outlined elsewhere (Polk et al., 2008). For the current study, reported age (years),
sex, education (years), and socioeconomic status (measured by a validated proxy, the
“community ladder” item of the MacArthur Scale of Subjective Social Status; Adler & Stewart,
2007; See Appendix B) were the demographic variables utilized.
Fear of Pain Questionnaire-9. The Fear of Pain Questionnaire-9 is a self-report measure
of fears about pain, generally (FPQ-9; McNeil et al., 2017). The 9-item instrument contains three
factor analytically derived subscales: Fear of Severe Pain, Fear of Minor Pain, and Fear of
Medical/Dental Pain. Responses are made using a 5-point Likert-type scale; an indication of how
fearful the respondent is of the pain associated with each of several painful experiences is
provided. The FPQ-9 assesses fears about pain induced by a broad range of stimuli or situations.
The instrument is presented in Appendix C. Each subscale contains three items and possible
scores range from 3-15; possible total score ranges from 9-45. Higher scores are indicative of
greater levels of fear of pain.
The FPQ-9 was developed from the longer Fear of Pain Questionnaire-III (FPQ-III;
McNeil & Rainwater, 1998). The FPQ-III has established norms for clinical (i.e., chronic pain
patients, general medical outpatients) and nonclinical populations, and well-evidenced reliability
and validity (McNeil & Rainwater, 1998; Osman, Breitenstein, Barrios, Gutierrez, & Kopper,
2002; Roelofs et al., 2005). The FPQ-9 retains the factor structure of the FPQ-III (Randall,
Waddell et al., 2013) and has similarly strong reliability and validity as the FPQ-III (McNeil et
al., 2017). It has been used with success in several studies (e.g., Randall et al. 2012). For its
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strong psychometric properties and utility, and its ability to tap general fear of pain, this
instrument is of value for the current study.
Dental Fear Survey. The Dental Fear Survey (DFS) is a 20-item, self-report measure of
fearful and anxious reactions to dental stimuli and situations (Kleinknecht, Klepac, & Alexander,
1973; see Appendix D). The instrument assesses both physiological and behavioral responses to
dental situations (e.g., increased heart rate during dental treatment, avoidance of treatment via
appointment cancellation). Additionally, the instrument assesses severity of the fear response to
various dental stimuli (e.g., the dental chair, the anesthetic needle, the sound of the drill). Using a
5-point Likert-type scale, respondents rate how much each physiological or behavioral response
occurs or how much fear/anxiety they experience when presented with fear-inducing dental
stimuli. Total sore ranges from 20-100; higher scores indicate greater levels of dental carerelated fear. Three factor analytically derived subscales comprise the DFS: one related to
anticipatory anxiety and treatment avoidance, one related to fear of specific stimuli, and the other
related to physiological arousal associated with dental treatment/stimuli (Kleinknecht et al.,
1973).
The DFS is very widely used in behavioral dentistry research because of its strong
psychometric properties. Stability in the factors and scores across time has been observed in both
clinical and nonclinical samples (Kleinknecht et al., 1973) and internal consistency and testretest reliability has been confirmed (Kleinknecht, Thorndike, McGlynn, & Harkavy, 1984;
McGlynn, McNeil, Gallagher, & Vrana, 1987). Predictive, convergent, and discriminant validity
also has been observed (Smith & Moore, 1994; Wilson & Sinisko, 1997). A critical review of
anxiety and pain measures in dentistry resulted in the suggestion that the DFS be used to measure
dental care-related fear in research applications involving adults (Newton & Buck, 2000). Given
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its psychometric properties and comprehensiveness, the DFS is preferable in research settings to
other measures of dental care-related fear (Newton & Buck, 2000), such as Corah’s Dental
Anxiety Scale (used in the Binkely et al. [2009] study), and as such is utilized in the current
study. It should be noted, however, that the DFS, while important historically and currently, has
been criticized for not being based on theory. For instance, the DFS utilizes a single summary
score without a clear rationale and may be more appropriate for clinical practice than for
research (Armfield, 2010b). While other and more recent dental care-related fear self-report
assessments exist (e.g., Armfield, 2010b), the DFS has been used extensively (Armfield, 2010a)
and continues to have utility, particularly in comparing results in longitudinal investigations and
cross-sectionally in comparison to prior studies. Participants of the COHRA1 study completed
the DFS and FPQ-9 as part of the larger battery of study questionnaires.
DNA Collection and Available Genetic Data
During the early part of the COHRA1 study, DNA was collected for all consenting
participants from blood samples procured by trained phlebotomists from peripheral veins (Polk
et al., 2008). The majority of COHRA1 study participants, however provided saliva or cheek
swab samples from which DNA was extracted (Polk et al., 2008). The change in DNA collection
method resulted from the availability of improved methodologies, allowing reliable extraction
from saliva. Collected DNA was genotyped on an Illumina platform (600,000 SNPs). The
genotype data already have been extensively validated, cleaned, quality checked, and formatted
for statistical analysis (see Data Cleaning Report; Marazita, 2010).
Though the MC1R gene was not explicitly sequenced for each COHRA1 study
participant, 31 SNPs within the MC1R coding region had been genotyped or imputed, and those
data were available for the study sample. Each of these SNPs were considered for use in analyses

27
for the present study, though only 6 ultimately, were utilized. In determining MC1R gene variant
status in a similar study, Binkely and colleagues (2009) determined the genotype of each
participant at 12 SNPs, and sequenced the entire coding region of the gene for approximately
half of their sample. In the end, the authors of that study utilized only eight SNPs to determine
MC1R variant status, based on results of a study indicating the MC1R SNPs that most likely
significantly decrease the function of the gene (Binkely et al., 2009; García-Borrón, SánchezLaorden, & Jiménez-Cervantes, 2005). To be congruent with the Binkely et al. (2009) study on
the relation between MC1R gene variants and dental care-related fear, this study involved
labeling as variant minor allele(s) the same SNP(s). The data available for this project included
six of the SNPs targeted by Binkely and colleagues (2009), and notably the MC1R SNP most
well-known for being related to pain sensitivity and/or decreased anesthetic efficacy (i.e.,
rs1805007). The following SNPs were analyzed for the present study: rs1805006, rs11547464,
rs1805007, rs1110400, rs1805008, rs1805009 (labeled using protein product notation in the
Binkley et al. [2009] study: D84E, R142H, R151C, I155T, R160W, and D294H, respectively).
These SNPs were chosen not only for comparability to the study by Binkley and colleagues
(2009), but, like in that study, also based on their likelihood of affecting MC1R function. Minor
alleles at these six SNPs are missense (coding) variants responsible for amino acid residue
changes that are predicted to be deleterious to protein function (García-Borrón et al., 2005). The
SNPs are moderate (<10%) to low (<1%) frequency coding variants and linkage disequilibrium
among them is low (r2 < 0.2; see Table 1).
Determining MC1R Variant Status
For the proposed project, genetic data were combined across SNPs to calculate a risk
score, as was done by Binkely and colleagues (2009). Variant (i.e., minor) alleles were
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determined by referencing SNPedia (http://www.snpedia.com) and GeneCards
(http://www.genecards.org) and are reported with study results as consistent with similar
literature (e.g., MacQueen et al., 2014). Participants were assigned to one of two groups based on
the number of SNPs for which they carry a minor allele: zero target SNPs, or one or more target
SNPs. Variant status thus describes whether MC1R variations are present. Participants with
minor allele(s) at one or more target SNPs were considered to have positive variant status, and
participants with no variation at these SNPs were considered to have negative variant status.
With regard to determination of MC1R variant status, study results do not differ based on method
of MC1R variant group assignment. For example, very similar (and not statistically different)
results are obtained when participants are sorted into the following three groups: participants
with zero variant alleles, participants with one variant allele, and participants with two (or more)
variant alleles.
Determining MC4R, OPRM1, COMT, and SCN9A Variant Status
As noted earlier, the MC4R gene is potentially functionally related to the MC1R gene,
though the two are on different chromosomes (i.e., MC4R is on chromosome 18). A common
MC4R SNP (Chowdhury et al., 2013) was selected to be used in analyses for the present study:
rs11872992. Presence of the minor allele was labeled as variant for the study. OPRM1 variation
has been associated with pain perception; rs 1799971 (i.e., A118G) is the OPRM1 SNP that has
been linked to experimentally-induced pain sensitivity (Fillingim et al., 2005), and for which
presence of the minor allele was labeled as variant for these study analyses. With regard to
COMT, participants with the minor allele at one or both of two SNPs (rs6269 and rs4818) were
labeled as variant. These SNPs are highly predictive of the role of COMT in temporomandibular
joint disorder (TMD; Diatchenko et al., 2005). Lastly, and similarly, participants with the minor
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allele at one or both of two SNPs (rs6746030 and 41268673) on SCN9A, which have been
associated with pain disorders (e.g., Reimann et al., 2010), were labeled as variant.
Statistical Analyses
Following determination of MC1R variant status for all participants, demographic, fear of
pain, and dental care-related fear data were merged with genetic data, and quality of the data
merging process was checked. Missing data for demographic variables were accounted for using
regression imputation; 1 participant was missing age data, 10 participants were missing
education data, and 21 participants were missing subjective social status data. The same process
was utilized to account for missing FPQ-9 and DFS data, as outlined by Randall and colleagues
(2013). There were no missing genetic data for the study sample. As is recommended in the
literature (Tabachnick & Fidell, 2007), univariate outliers were screened for by considering
standardized scores; none were found. All statistical analyses were performed using SPSS
Statistics 21 (IBM SPSS, Chicago, IL) and the PROCESS macro (Hayes, 2013) for SPSS
Statistics. Effect size calculations (i.e., Cohen’s d) for t-tests were conducted using Effect Size
Calculators (Becker, 1999).
Results
Sample Characteristics, Fear of Pain, and Dental Care-Related Fear
First, descriptive statistics (e.g., means and standard deviations) were calculated, and
bivariate correlational analyses were employed to determine the relation between fear of pain,
dental care-related fear, age, education, and socioeconomic status for the total sample. The
sample of 817 participants comprised 511 females (62.5%), and mean age was 34.7 years (SD =
8.7, range = 18-67). Participants had, on average, 13.1 years of education (SD = 2.5, range = 4-
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23). The average response on the “community ladder” item of the MacArthur Scale of Subjective
Social Status was 5.7 (SD = 2.0, range = 1-10).
Mean FPQ-9 score was 23.2 (SD = 8.1. range = 9-45) and mean DFS score was 39.2 (SD
= 19.2, range = 20-100). Mean subscale scores for both measures are listed in Table 2. Average
FPQ-9 and DFS scores were consistent with those observed in studies of similar populations
(e.g., Randall et al., 2012). As has been previously reported for this sample (Randall et al.,
2016b), distributions of FPQ-9 and DFS matched existing research: negatively skewed, with
nearly 15% of participants reporting extremely high levels of fear of pain and/or phobic levels of
dental care-related fear. Bivariate correlations between demographic variables and FPQ-9 and
DFS scores are listed in Table 3.
Basic between-group comparisons (i.e., t-tests) were utilized to determine whether there
are differences in general fear of pain and dental care-related fear between males and females for
the total sample. Females reported higher (FPQ-9 M = 24.6, SD = 7.9) and males reported lower
(FPQ-9 M = 21.2, SD = 7.8) levels of fear of pain, t(815) = 5.9, p < 0.001, Cohen’s d = .41.
Likewise, females reported higher (DFS M = 40.3, SD = 19.6) and males reported lower (DFS M
= 37.5, SD = 18.2) levels of dental care-related fear, t(815) = 2.0, p = .04, Cohen’s d = .14. This
sex difference, of small effect size, has been widely observed, specifically in dental care-related
fear, and across many fears (see Craske, 2003; McNeil & Randall, 2014). Demographic data and
FPQ-9 and DFS subscale data, divided by sex, are reported in Table 4. Age and subjective social
status were not significantly associated with FPQ-9 or DFS scores; education was not
significantly associated with FPQ-9 score and was significantly, but only weakly, associated with
DFS score (see Table 3). In light of these findings, sex, but not other demographic variables, was
controlled for in subsequent analyses.
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MC1R Variation
In total, 546 participants had no MC1R risk variants, 249 had one risk variant, and 22 had
two risk variants; no participant had more than two variants. Thus, 271 participants (33.2%) had
at least one risk allele, a proportion consistent with that observed in the dark-haired Caucasian
(i.e., not redhead) subsample of the only other similar study (Binkely et al. 2009). Table 5
summarizes the proportion of the sample with MC1R risk alleles for each of the study SNPs, and
notes minor allele for each of the SNPs.
Basic between-group comparisons (i.e., chi-square, t-tests) were utilized to determine
whether there were sex, age, education, or socioeconomic differences between positive and
negative MC1R variant status. Given that there exist potential sex differences in the heritability
of dental care-related fear (Ray et al., 2010) and that the influence of MC1R on pain perception
may be sex-specific (Delaney et al., 2010), it was imperative to test the effect of sex on MC1R
variant status. In this sample, females and males did not differ in their likelihood of having one
or more MC1R risk alleles, X2 (2, N = 817) = 1.86, p = .17 (160 of 511 females and 110 of 306
males in the sample had one or more MC1R variant). Similarly, presence of risk alleles at one or
more MC1R SNPs was not associated with age, t(815) = 1.4, p = .15, education, t(815) = .25, p =
.80, nor subjective social status, t(815) = 1.23, p = .22.
MC1R Variation, Fear of Pain, and Dental Care-Related Fear
To address Hypotheses 1 and 2, that MC1R gene variant status predicts dental carerelated fear and fear of pain, respectively, multiple linear regression analyses were utilized. An
additive hierarchical regression was conducted with MC1R gene variant status as the independent
variable and either dental care-related fear or fear of pain as the dependent variable, controlling
for covariates (i.e., sex). There were no issues with muticollinearity.
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MC1R variant status was predictive of dental care-related fear, F(2,814) = 4.20, p = .02,
R2 = .01, controlling for sex. Likewise, MC1R variant status was predictive of general fear of
pain, F(2,814) = 21.08, p < .001, R2 = .05, controlling for sex. Presence of one or more MC1R
variant(s) was associated with increased DFS and FPQ-9 scores. See Table 6 for results of
regression analyses.
The MC1R variant status scoring scheme used in this study (i.e., calculating a risk score
by determining whether participants had variation at either none or one or more of six SNPs, as
in Binkely et al. [2009]) may mask the reporting of individual SNPs and the association among
genetic variation and phenotype. Thus, the association of variation at each of the study SNPs
with DFS and FPQ-9 scores was investigated independently by SNP. Those results are presented
in Table 7. For only one SNP, rs1805007, presence of the minor allele significantly predicted
DFS and FPQ-9 scores. The other SNPs were not significantly related to either dental carerelated fear nor fear of pain and showed large standard errors of their effect estimates, indicating
insufficient power to precisely model their effects. Additionally, variation at four of the six SNPs
is relatively rare in this sample. As such, study results appear to be driven predominantly by
variation at rs1805007.
To address Hypothesis 3, that fear of pain mediates the relation between MC1R variant
status and dental care-related fear, mediation was tested using the PROCESS macro (Hayes,
2013) for SPSS Statistics. Relative indirect effects were subjected to post hoc bootstrap analyses
with 5000 samples and a 95-percentile confidence interval estimate. PROCESS allows for
dichotomous independent variables in mediational analyses as well as analysis of data that are
not normally distributed (as in the case of the DFS and FPQ-9 data in the current study), and is
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the contemporary strategy of choice for determining mediation effects in research with
psychological phenomena.
FPQ-9 and DFS scores were moderately correlated (r = .50, p < .001). Given, this
association, and the well-supported suggestion that fear of pain is a primary component of dental
care-related fear (McNeil & Berryman 1989), a single mediator model was tested with fear of
pain (FPQ-9 score) as the mediating variable to explain the association between MC1R variant
status and dental care-related fear (DFS score); see Table 8 and Figure 3. Full mediation was
observed. There was a significant indirect effect of MC1R variant status on dental care-related
fear through fear of pain, B = 1.60, BCa CI [0.281, 3.051]. The size of this effect was small to
moderate, ĸ2 = .044, 95% BCa CI [.009, .082].
Exploratory Analyses
To complete the secondary and exploratory objective of this study, the same general
statistical approach as was used for the MC1R data was used to determine whether variants of the
MC4R, OPRM1, COMT and SCN9A genes were associated with fear of pain and/or dental carerelated fear, given the literature summarized earlier.
MC4R. Of 817 participants, 207 (25.3%) had risk a risk allele at the MC4R SNP
genotyped for this study (rs11872992). MC4R variation was not associated with MC1R variation,
X2 (2, N = 817) = .86, p = .36. Controlling for sex, MC4R variation was predictive of lower DFS
score (for participants with the MC4R risk allele, DFS M = 36.8, SD = 18.4; for participants
without MC4R risk allele, DFS M = 40.1, SD = 19.4), F(2,814) = 4.04, p = .02, R2 = .01. Results
of the regression model used to test this association are presented in Table 9. There was no
difference in FPQ-9 score between participants with and without MC4R variation, t(815) = 1.8, p
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= .07. Given that there was no significant relation between MC4R variant status and fear of pain,
follow-up mediational analysis was not warranted.
OPRM1, COMT, and SCN9A. In this sample, 181 (22.2%) participants had the risk
allele for the OPRM1 SNP analyzed. Variance on the OPRM1 gene was associated with neither
FPQ-9 score, t(815) = .06, p = .96, nor DFS score, t(815) = .78, p = .43. The prevalence of
participants with risk allele(s) at one or both of the COMT SNPs analyzed for this study was
62.2% (n = 508). COMT variance was not associated with FPQ-9 score, t(815) = .62, p = .54, nor
DFS score, t(815) = .41, p = .68. Approximately one-third (31.7%; n = 259) of the participants
had risk allele(s) at one or both of the SCN9A SNPs analyzed for the study. SCN9A variance had
no association with FPQ-9 score, t(815) = .45, p = .65, nor DFS score, t(815) = .26, p = .80.
Discussion
As expected, MC1R variant status is associated with dental care-related fear. Participants
with one or more risk alleles in the MC1R coding region were more likely than those with none
to report greater levels of dental care-related fear on the DFS, supporting Hypothesis 1. MC1R
variant status also is associated with general fear of pain. In support of Hypothesis 2, participants
with one or more variants in the MC1R coding region were more likely than those with none to
report greater levels of fear of pain, as measured by the FPQ-9. Perhaps most fascinating – and
important – is the finding that the relation between MC1R variant status and DFS score is
explained by FPQ-9 score. That is, fear of pain fully mediates the relation between MC1R variant
status and dental care-related fear, providing support for Hypothesis 3. Interestingly, variation at
one study SNP, rs1805007, appears to drive these observed associations.
Critically, these findings extend those of the few other studies on the topic of genetic
contributions to dental care-related fear. As mentioned earlier, three studies have demonstrated
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moderate to high heritability for dental care-related fear (30-47%; Randall et al., 2016b; Ray et
al., 2010; Vassend et al., 2011). And, as highlighted previously, Binkely and colleagues (2009)
determined that MC1R variant status (i.e., having one or more gene variants versus no variants)
predicts greater fear of dental pain and dental care-related fear, as well as a two-fold increase in
the likelihood of avoiding dental care. Results of the current study provide the first known
confirmation of the primary findings reported by Binkley and others (2009), replicating the result
of the only other known study on the topic. Taken together, it is clear that the experience of
dental care-related fear is influenced by genetic factors. Moreover, the MC1R gene appears to be
linked to dental care-related fear, and may be especially important in the development and
maintenance of dental care-related fear for some people.
If the literature on the etiology of dental care-related fear is scant with data informing our
understanding of genetic contributions, then the same can be said about the fear of pain
literature. Notably, only one study has addressed the heritability of general fear of pain,
demonstrating a moderate degree (i.e., 34%) in a community sample of adolescents and adults,
the same sample from which the current data are drawn (Randall et al., 2016b). Only two other
studies provide evidence for potential genetic contributions to the experience of fear of pain.
First, the same study that demonstrated a link between MC1R variation and dental care-related
fear (Binkley et al., 2009) also showed that MC1R risk alleles are predictive of fear of dental
pain, a distinct from, though partially overlapping, general fear of pain (van Wijk, McNeil, Ho,
Buchanan, & Hoogstraten, 2006). Second, the 5-hydroxytryptamine (serotonin) receptor 3B gene
(HTR3B) has been associated with pain catastrophizing, a phenomenon that overlaps partially
with fear of pain (Horjales-Araujo et al., 2013). There is a budding literature on how genetic
variation may play a role in the development and manifestation of fear of pain, and this study
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contributes to that literature. The present study offers evidence that there are genetic influences
in the experience of fear of pain, and is the first to implicate MC1R variation as a contributor to
general fear of pain.
Building on existing work summarized here, this study demonstrates that the association
between MC1R risk alleles and dental care-related fear is through an association between MC1R
variation and fear of pain, and is the first to do so. By extension, this finding offers preliminary
biological support for the well-documented notion that fear of pain is a primary component of
dental care-related fear (McNeil & Berryman, 1989). Equally or perhaps even more interesting,
results of the current study suggest that the role of genetic factors in the development and
maintenance of dental care-related fear may be through pain-related phenomena. That fear of
pain is the mediating variable in the association between MC1R variant status and dental carerelated fear suggests that genetically-influenced differences in pain experience (e.g., pain
threshold, tolerance) are potential cause for fear of pain, which may then underpin dental carerelated fear.
As observed in a number of studies, MC1R variation is associated with heightened
sensitivity to pain, including dental pain specifically (e.g., Delaney et al., 2010; Liem et al.,
2005; Mogil et al., 2005). The experience of acute and chronic pain can trigger and/or exacerbate
fear of pain, which in turn can influence pain perception and pain behavior. For instance, those
who have experienced acute and/or chronic orofacial pain are more likely than those who have
not to later report fear of pain (van Wijk & Hoogstraten 2005). And, those with higher levels of
fear of pain are more likely to perceive pain stimuli as more intense (van Wijk & Hoogstraten
2009), to engage in pain catastrophizing (Parr et al. 2012), and to engage in avoidance behaviors
that worsen the pain experience (Lee et al. 2007). Of course, and as was replicated in the current
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study, fear of pain is moderately to strongly correlated with dental care-related fear, which is
predictive of dental treatment avoidance (e.g., Armfield et al., 2007; Doerr et al., 1998).
Conceivably, then, MC1R risk alleles may predispose some people to be more sensitive to pain
than others, leading them to have more negative (i.e., painful) experiences with dental treatment.
This, in turn, may make those individuals more likely to develop fears about pain and associated
fears about dental treatment, and, ultimately, to avoid dental treatment with greater frequency.
Comment on Results of Exploratory Analyses
Given existing literature, it was expected that variation in genes in addition to MC1R
would be associated with fear of pain and/or dental care-related fear, and so it was surprising that
none of the exploratory analyses afforded meaningfully significant results. For the exploratory
analyses, MC4R was chosen as a candidate gene because of its known association with anxiety
behavior (Chaki & Okuyama, 2005). Similarly, OPRM1, COMT, and SCN9A were chosen as
candidate genes for exploratory analyses for their known associations, generally, with pain
sensitivity and pain perception (e.g., Andersen & Skorpen, 2009; Drenth & Waxman, 2009;
Fillingim et al., 2005). COMT, for example, has even been implicated as important in influencing
the orofacial pain experience, as COMT variation is associated with chronic TMD (e.g., Smith et
al., 2011).
MC4R was the only candidate gene associated with dental care-related fear, and neither
MC4R nor the other candidate genes included in the exploratory analyses were associated with
fear of pain. It is difficult to offer conjecture on these negative results. However, it may be the
case that variation in these genes is not associated with dental pain sensitivity, and that the
genetic influence on dental pain sensitivity, specifically, is important in any relation between
gene variation and dental care-related fear. Though the SNPs analyzed for each of these genes
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were chosen for their documented associations with pain sensitivity and/or other pain-related
phenomena, it also may be the case that other SNPs on these candidate genes would have served
as better markers of relations between genes and fear of pain and/or dental care-related fear,
should such relations exist. Lastly, it may be the case that the study sample was not large and/or
diverse enough to detect associations between the candidate genes and fear of pain and/or dental
care-related fear. Future work on influence of genetic factors on dental pain, fear of pain, and
dental care-related fear should include these genes in order to further establish their role (or nonrole) in those phenotypes.
Implications of the Study
Generally, the results of this study strengthen the conceptualization of dental care-related
fear in that they confirm an etiological role of genetics. Moreover, the results provide additional
evidence for a pain-related genetic contribution to the etiology of dental care-related fear.
Importantly, the critical roles of pain and fear of pain are underscored by the study findings.
Dental care-related fear, with fear of pain as its primary component, most certainly impacts the
orofacial pain experience, and is impacted by the orofacial pain experience. The bidirectional
influence of orofacial pain on dental care-related fear is well documented, as described above. In
worst case scenarios, patients can become caught in a “vicious cycle” of dental care-related fear.
In such cases, patients have a painful dental experience, subsequently develop dental care-related
fear as a result of aversive conditioning, then avoid necessary dental treatment due to fear, only
to have the fear perpetuated when they finally must seek dental treatment that inevitably is
especially painful due to neglect (and would otherwise not have been painful if they had not
engaged in fear-related avoidance; see Armfield et al., 2007). If patients are genetically
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predisposed to be hypersensitive to orofacial pain (perhaps through MC1R gene variation), it
follows that they are more likely to end up in such a cycle.
In addition to operating through pain-related mechanisms, there may be a small but
potentially important involvement of genetics in dental care-related fear through influence on
other important psychological variables. For example, genetic variability may influence basic
learning (e.g., conditioning, sensitization, desensitization) in ways that promotes or buffers
development/maintenance of dental care-related fear. Because the systemic, oral, and
psychological health burdens of dental care-related fear are so profound, a complete
conceptualization of the phenomenon is essential. Drawing on the results of this study, future
research in the areas of fear of pain and dental care-related fear should incorporate genetic
variables, including MC1R, whenever possible, in order to elucidate their most comprehensive
conceptualizations.
From a clinical standpoint, and at the most basic level, results from this study suggest that
targeting fear of pain may promote successful amelioration of dental care-related fear. In
addition, attending to the idiographic pain experiences of patients may be useful in the treatment
of fear of pain and/or dental care-related fear. This study demonstrates promise in the utilization
of biomarkers to inform dental treatment planning. Given study results, it may be that knowledge
of a patient’s MC1R status could allow his/her dental care provider to tailor treatment so as
buffer the patient from increased risk of fear of pain and dental care-related fear, a la
personalized medicine/dentistry. For the practicing dental professional, for example and
hypothetically, this may take the form of screening patients for MC1R variation early in life, and
adapting dental treatment protocol to ensure that those with variants receive particularly
comfortable care to reduce their likelihood of experiencing aversive or traumatic dental treatment
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and, ultimately, to reduce their likelihood of developing fear of pain and/or dental care-related
fear. Such a recommendation is, of course, premature at this point. Additional research is
necessary to uncover the mechanisms by which MC1R variation is related to fear of pain and the
critical biological pathways involved. Additional research also is necessary to determine the
most efficacious ways to utilize knowledge of MC1R variant status to inform clinical practice,
both for the dental clinician, who may be concerned with pain and fear management, and the
mental health clinician, who may be concerned with the treatment of already-developed fears
about pain and/or dentistry.
Limitations
Study limitations include, first, that as a function of utilizing archival data from a larger
project aimed at addressing oral health in Appalachia, the sample is geographically and culturally
restricted and results may not be generalizable. Replication with samples from other areas is
necessary. Moreover, this study and the only other one suggesting a link between MC1R and
dental care-related fear, analyzed data for only Caucasian/white participants. To more thoroughly
and accurately understand the role of MC1R variation in the experience of dental care-related
fear, and to simultaneously offer a more nuanced understanding of that association and improve
generalizability, the same analyses must be completed with members of other ethnic/racial
groups. Additionally, self-reported ethnicity/race was used to select cases for study analyses and
so may not match genetic ancestry. Future studies should verify participant ethnicity using
genotype data and, for samples that include multiple ethnicities, analyses should be stratified by
ethnicity/race or adjusted for using principal components of ancestry.
A second limitation of this study is the reliance of self-report instruments to measure the
phenotypes of interest. While the questionnaires utilized are psychometrically strong, multimodal
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and behavioral assessment of fear of pain and dental care-related fear would strengthen future
study design. Third, no measure of dental treatment-seeking behavior (e.g., time since last dental
visit) was utilized. Dental care-related fear certainly is an important phenotype in its own right;
however, whether a patient’s dental treatment–seeking behavior is reduced due to fear is
ultimately most important. Those data were not available for the current study, but should be
included in future work on the topic. It also may be helpful to include as a study variable (and
control for) history of dental trauma, including previous experiences of particularly painful
dental treatment. Such data, and no good proxy for such a variable, was available for the current
sample. Lastly, available data are cross sectional, which limits conclusions that can be drawn
from mediational analyses. Longitudinal data may allow for stronger claims to be made about the
causal relations between genetic variation, fear of pain, dental care-related fear, and dental
treatment-seeking behavior.
Directions for Future Research
Future research should utilize experimental measures of the orofacial pain experience
(e.g., quantitative sensory testing) to determine how MC1R and other gene variants are related
specifically to orofacial pain perception and to clarify whether orofacial pain sensitivity bridges
the path between MC1R variant status and fear of pain (and associated dental care-related fear).
Given the results of the current study, and those that demonstrate that MC1R may be important
for sensitivity to pain, such an exploration is warranted. Follow-up studies also should test
whether MC1R variation is related to orofacial pain sensitivity, specifically, or general pain
sensitivity (and, similarly, whether MC1R variation is related to dental care-related fear,
specifically, or fear of medical and other healthcare procedures, broadly). Moreover, there should
be studies that address how MC1R SNPs affect protein expression and function, and associated
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downstream effects, so that the mechanism(s) by which gene variation is associated with fear of
pain and dental care-related fear can be elucidated. Studies that expand understanding of the
specific role(s) of genes like MC1R may provide additional avenues by which to target pain
hypersensitivity and fear of pain that can contribute to dental care-related fear. Gene-byenvironment studies of the influence of genetics on pain perception, fear of pain, and/or dental
care-related fear also may be warranted, particularly given the theoretical understanding of the
relations between these constructs and their impact on dental treatment-seeking patterns as
posited by McNeil and Randall (2014).
The regression models presented here, linking MC1R variation, fear of pain, and dental
care-related fear, account for only a small proportion of the variance in fear of pain and dental
care-related fear (i.e., 1-5%). As noted earlier, heritability of fear of pain and dental care-related
fear is moderate to high (Randall et al., 2016b). Thus, it is likely that there are genes in addition
to MC1R that may influence fear of pain and dental care-related fear through involvement in pain
and/or anxiety pathways or by other means. Future work in the area of genetic influences on fear
of pain and dental care-related fear should include genes other than those that were the focus of
this study so as to provide an even more comprehensive picture.
Summary
To conclude, this study corroborates previous work suggesting that MC1R variants are
associated with dental care-related fear. The study is the first to show that MC1R variant status
predicts general fear of pain. And, most importantly, results presented here indicate that fear of
pain plays a mediational role in the association between MC1R variant status and dental carerelated fear. Critically, it is clear that genetic variation contributes to the etiology of dental carerelated fear. This study demonstrates promise in the potential further identification of biomarkers
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that may be useful in determining and personalizing dental treatment. Moreover, these results
have important implications for how we understand psychosocial correlates of orofacial pain and
dental treatment-seeking behavior, and provide possible specific targets for the treatment of
orofacial pain, fear of pain, and/or dental care-related fear.
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Footnotes
1

‘Dental care-related fear and anxiety’ represents the most precise terminology to describe the

phenomena that may be experienced in the context of dental and dental-related stimuli that are
perceived to be threatening. As described in more detail below, dental care-related fear and
dental care-related anxiety are related but distinct constructs that can occur independently of one
another and/or concurrently (i.e., “mixed”) in individuals (McNeil, Vargovich, Turk, & Ries,
2012). Indeed, limited research on the etiology, assessment, and treatment of dental care-related
fear and anxiety has attempted to disentangle the two, and the phenomena often are confused for
one another, treated as the same, and/or considered in tandem. See McNeil & Randall (2014) for
a comprehensive commentary on this issue. For simplicity, the term ‘dental care-related fear’ is
used throughout.
2

Of note, Caucasian/white participants (i.e., those included in the current study sample and for

whom data were analyzed) were not statistically different from their non-Caucasian/white
counterparts in the full COHRA1 sample on the proportion of females to males, age, years of
education, socioeconomic status (i.e., the “community ladder item of the MacArthur Scale of
Subjective Social Status, described below), nor level of dental care-related fear (i.e., Dental Fear
Survey score, described below). However, Caucasian/white participants had, on average, lower
levels of fear of pain (i.e., Fear of Pain Questionnaire-9 score, described below) than did their
non-Caucasian/white counterparts (M = 23.3, SD = 8.1 for Caucasian/white participants, M =
25.7, SD = 9.3 for non-Caucasian/white participants), t(897) = 2.54, p = .01. As expected,
likelihood of having one or more MC1R variant (method of genotyping and determining of
variant status described below) was greater for Caucasian/white participants than for nonCaucasian/white participants, X2 (1, N = 911) = 14.70, p < .001 (271 of 817 Caucasian/white
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participants and 13 of 94 non-Caucasian/white participants in the full COHRA1 sample had one
or more MC1R variant). Likewise, likelihood of having the MC4R variant was greater for
Caucasian/white participants than for non-Caucasian/white participants, X2 (1, N = 911) = 5.00, p
= .025 (207 of 817 Caucasian/white participants and 14 of 94 non-Caucasian/white participants
in the full COHRA1 sample had the MC4R variant). The same trend was observed for OPRM1,
X2 (1, N = 911) = 6.75, p = .009 (181 of 817 Caucasian/white participants and 10 of 94 nonCaucasian/white participants in the full COHRA1 sample had the OPRM1 variant), and for
SCN9A, X2 (1, N = 911) = 6.28, p = .012 (259 of 817 Caucasian/white participants and 18 of 94
non-Caucasian/white participants in the full COHRA1 sample had one or more SCN9A variant).
Caucasian/white and non-Caucasian/white participants in the full COHRA1 sample did not differ
significantly in their likelihood of having one of more COMT variant. The relatively large
difference in size of the Caucasian/white and non-Caucasian/white subsamples is acknowledged
as a limitation.

67
Table 1
Linkage Disequilibrium (r2) Among Genotyped MC1R SNPs

rs1110400
rs11547464
rs1805006
rs1805007
rs1805008

rs11547464

rs1805006

rs1805007

rs1805008

rs1805009

.00008

.02

.0004

.002

.0001

.00005

.0009

.0009

.00002

.0004

.003

.00006

.003

.0004
.0009
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Table 2
Mean FPQ-9 and DFS Total and Subscale Scores
M

SD

Range

23.2

8.1

9-45

Minor Pain
Subscale

6.0

2.4

3-15

Severe Pain
Subscale

9.8

3.7

3-15

Medical Pain
Subscale

7.6

3.3

3-15

39.2

19.2

20-100

Avoidance
Subscale

13.2

7.4

8-40

Fear of Specific
Stimuli Subscale

14.8

7.5

6-30

Physiological
Arousal Subscale

9.2

4.8

5-25

Total FPQ-9

Total DFS

Note. N = 817.
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Table 3
Bivariate Correlations between Demographic Variables, FPQ-9 Score, and DFS Score

Age
Education
Subjective
Social Status
Total FPQ-9
Score

Education

Subjective
Social Status

Total FPQ-9
Score

Total DFS
Score

.15***

.16***

.06

.02

.19***

-.03

-.11**

-.003

-.05
.50***

Note. Correlation statistic = Pearson correlation coefficient (r). **p < .01. ***p < .001.
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Table 4
Demographic, FPQ-9, and DFS Data by Participant Sex
Females

Males

M

SD

Range

M

SD

Range

Age (years)

33.6

8.1

18-66

36.7

9.4

20-67

Education (years)

13.1

2.3

7-22

12.8

2.7

4-23

Subjective Social
Status

5.7

2.0

1-10

5.8

2.0

1-10

Total FPQ-9

24.6

7.9

9-45

21.2

7.8

9-45

Minor Pain
Subscale

6.2

2.4

3-15

5.6

2.4

3-15

Severe Pain
Subscale

10.4

3.7

3-15

8.8

3.6

3-15

Medical Pain
Subscale

8.1

3.3

3-15

6.7

3.1

3-15

40.3

19.6

20-100

37.5

18.2

20-100

Avoidance
Subscale

13.4

7.7

8-40

12.8

7.0

8-40

Fear of Specific
Stimuli Subscale

15.3

7.5

6-30

13.9

7.2

6-30

Physiological
Arousal Subscale

9.4

5.0

5-25

8.8

4.4

5-25

Total DFS

Note. N = 817. Females n = 511. Males n = 306.
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Table 5
Proportion of Study Sample with Risk Alleles across Genotyped MC1R SNPs
SNP (minor allele)

Note. N = 817.

n

% of sample

rs1805008 (T)

132

16.2

rs1805007 (T)

126

15.4

rs1110400 (C)

18

2.2

rs1805006 (A)

10

1.2

rs1805009 (C)

4

.5

rs11547464 (A)

3

.4
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Table 6
Regression Models for MC1R Variant Status Predicting Dental Care-Related Fear and Fear of
Pain
DFS Total Score
Predictor Variable

FPQ-9 Total Score

B

SE

β

p

B

SE

β

p

Sex

2.93

1.38

.07

.03

3.45

.57

.21

< .001

MC1R Variant Status

2.94

1.41

.07

.04

1.53

.59

.09

.009

Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression
coefficient.
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Table 7
Independent Regression Models for Prediction of Dental Care-Related Fear and Fear of Pain by
Genotyped MC1R SNPs
DFS Total Score
Predictor Variable

FPQ-9 Total Score

B

SE

β

p

B

SE

β

p

Sex

2.80

1.38

.07

.04

3.38

.98

.20

< .001

rs1805008

.35

1.82

.007

.85

.68

.75

.03

.36

Sex

3.10

1.38

.08

.03

3.50

.57

.21

< .001

rs1805007

5.94

1.85

.11

.001

2.37

.76

.11

.002

Sex

2.80

1.38

.07

.04

3.38

.97

.20

< .001

rs1110400

2.24

4.56

.02

.62

-.17

1.88

-.003

.93

Sex

2.75

1.40

.07

.05

3.38

.57

.20

< .001

rs1805006

-7.88

6.08

-.05

.20

.28

2.52

.004

.91

Sex

2.84

1.38

.07

.04

3.39

.57

.20

< .001

rs1805009

-14.6

9.58

-1.52

.13

-6.24

3.96

-.06

.112

Sex

2.79

1.38

.07

.04

3.38

.57

.20

< .001

rs11547464

9.03

11.06

.03

.42

5.87

4.60

.04

.20

Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression
coefficient. Predictor variables labeled as MC1R SNPs (by rs number) refer to presence of minor
allele at indicated SNP. For the one SNP (rs1805007) for which presence of minor allele
significantly predicted dental care-related fear and fear of pain, bolded above, model statistics
are: F(2,814) = 7.23, p = .001, R2 = .02 (dental care-related fear [DFS Score]); F(2,814) = 22.58,
p < .001, R2 = .05 (fear of pain [FPQ-9 Score]). Threshold for statistical significance was set at p
= .008 after Bonferroni correction for multiple tests.
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Table 8
Mediation Model: Fear of Pain as Mediator between MC1R Variant Status and Dental CareRelated Fear
B

SE

t

p

CI (lower)

CI (upper)

X → M (a)

1.36

.60

2.28

.023*

.1917

2.5369

M → Y (b)

1.17

.07

16.17

< .001**

1.0306

1.3153

X → Y (c)

2.80

1.42

1.97

.049*

.0112

5.5895

X → Y (c’)

1.20

1.24

.97

.334

-1.2356

3.6358

X→M→Y

1.60

.71

.2812

3.0506

Note. X = MC1R variant status; M = FPQ-9 score (mediator); Y = DFS score;
B = Unstandardized regression coefficient; SE = Standard error; * p < .05; ** p < .001.
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Table 9
Regression Model for MC4R Variant Status Predicting Dental Care-Related Fear
DFS Total Score
Predictor Variable

B

SE

β

p

Sex

2.60

1.38

.07

.06

MC4R Variant Status

-3.06

1.54

-.07

.04

Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression
coefficient.
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Figure 1. Study variables and their theoretical connections, drawn from a comprehensive
conceptual model describing dental care-related fear. Adapted from: McNeil, D. W., & Randall,
C. L. (2014). Dental fear and anxiety associated with oral health care: Conceptual and clinical
issues. In D. Mostofsky & A. Fortune (Eds.), Behavioral dentistry (2nd ed., pp. 165-192). Ames,
IA: John Wiley & Sons, Inc. (See Appendix A).
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All COHRA1 participants
(n = 2,663)
Excluded: Participants who did not
complete DFS and FPQ-9
(i.e., those age < 11 years)
(n = 1,363)
All COHRA1 participants with
available genetic, DFS, and FPQ-9
data
(n = 1,300)
Excluded: Participants who are
first-degree relatives of other
participants in the sample (e.g.,
children or parents of probands)
(n = 389)

Genetically independent COHRA1
participants with available genetic,
DFS, and FQ-9 data
(n = 911)
Excluded: Non-Caucasian
participants
(n = 94)
§
§
§
§
§
§

Black / African American (n = 64)
Hispanic (n = 8)
Asian (n = 4)
Native American / Alaska Native (n = 2)
Other (n = 5)
Not reported (n = 11)

Participants included in study
analyses
(n = 817)
Figure 2. Selection of participants for study analyses. COHRA1 = Center for Oral Health
Research in Appalachia family-based study on determinants of oral disease, cohort 1. DFS =
Dental Fear Survey. FPQ-9 = Fear of Pain Questionnaire-9.
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Fear of Pain
B = 1.17, p < .001**

B = 1.36, p = .023*

MC1R Variant Status

Dental Care-Related
Fear

Direct effect: X → Y (c), B = 2.80, p = .049*
Direct effect: X → Y (c’), B = 1.20, p = .334
Indirect effect, B = 1.60, 95% CI [.2813, 3.0506]*
Figure 3. Fear of pain explains association between MC1R variant status and dental care-related
fear. X = MC1R variant status; Y = Dental Care-Related Fear (DFS Score); B = Unstandardized
regression coefficient; * p < .05; ** p < .001.
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Appendix A
Conceptual Model of Dental Treatment-Seeking Patterns

Reprinted from: McNeil, D. W., & Randall, C. L. (2014). Dental fear and anxiety associated with
oral health care: Conceptual and clinical issues. In D. Mostofsky & A. Fortune (Eds.),
Behavioral dentistry (2nd ed., pp. 165-192). Ames, IA: John Wiley & Sons, Inc.
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Appendix B
The MacArthur Scale of Subjective Social Status, Community Ladder Item

Reprinted from: Adler, N., & Stewart, J. (2007). The MacArthur Scale of Subjective Social
Status. Retrieved from: http://www.macses.ucsf.edu/research/psychosocial/subjective.php
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Appendix C

Fear of Pain Questionnaire – 9
INSTRUCTIONS: The items listed below describe painful experiences. Please look at each
item and think about how FEARFUL you are of experiencing the PAIN associated with each
item. If you have never experienced the PAIN of a particular item, please answer on the basis of
how FEARFUL you expect you would be if you had such an experience. Circle one number for
each item below to rate your FEAR OF PAIN in relation to each event.

I FEAR the PAIN associated with:
Not At All

A Little

A Fair
Amount

Very Much

Extreme

1.

Breaking your arm.

1

2

3

4

5

2.

Having a foot doctor
remove a wart from
your foot with a sharp
instrument.

1

2

3

4

5

3.

Getting a paper-cut on
your finger.

1

2

3

4

5

4.

Receiving an injection
in your mouth.

1

2

3

4

5

5.

Getting strong soap in
both your eyes while
bathing or showering.

1

2

3

4

5

6.

Having someone slam a
heavy car door on your
hand.

1

2

3

4

5

7.

Gulping a hot drink
before it has cooled.

1

2

3

4

5

8.

Receiving an injection
in your hip/buttocks.

1

2

3

4

5

9.

Falling down a flight of
concrete stairs.

1

2

3

4

5
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Appendix D
Dental Fear Survey
INSTRUCTIONS: The items in this questionnaire refer to various situations, feelings, and
reactions related to dental work. Please rate your feeling or reaction on these items by using the
following scales. Fill in the appropriate circle which most closely corresponds to your reaction.

Never

Once or
twice

A few
times

Often

Nearly
every time

1. Has fear of dental work ever caused you
to put off making an appointment?

○

○

○

○

○

2. Has fear of dental work ever caused you
__to cancel or not appear for an
__appointment?

○

○

○

○

○

When having dental work done:
Not At
All

A
little

Somewhat

Much

Very
much

3. My muscles become tense…

○

○

○

○

○

4. My breathing rate increases…

○

○

○

○

○

5. I perspire…

○

○

○

○

○

6. I feel nauseated and sick to my stomach…

○

○

○

○

○

7. My heart beats faster…

○

○

○

○

○

CONTINUED ON NEXT PAGE
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Following is a list of things, and situations that many people mention as being somewhat anxiety
or fear producing. Please rate how much fear, anxiety, or unpleasantness each of them causes
you. (If it helps, try to imagine yourself in each of these situations and describe what your
common reaction is.)
Not At
All

A
little

Somewhat Much

Very
much

8. Making an appointment for dentistry.

○

○

○

○

○

9. Approaching the dentist’s office.

○

○

○

○

○

10. Sitting in the waiting room.

○

○

○

○

○

11. Being seated in the dental chair.

○

○

○

○

○

12. The smell of the dentist’s office.

○

○

○

○

○

13. Seeing the dentist walk in.

○

○

○

○

○

14. Seeing the anesthetic needle.

○

○

○

○

○

15. Feeling the needle injected.

○

○

○

○

○

16. Seeing the drill.

○

○

○

○

○

17. Hearing the drill.

○

○

○

○

○

18. Feeling the vibrations of the drill.

○

○

○

○

○

19. Having your teeth cleaned.

○

○

○

○

○

20. All things considered, how fearful are you
___of having dental work done?

○

○

○

○

○

